Abstract
Lyngbyaloside C, a classic macrolide, isolated from Lyngbya bouilloni, has shown moderate anticancer activity against several cancer cell lines. Here, we report the first total synthesis and stereochemical configuration reassignment of lyngbyaloside C. The synthesis highlights a one-pot intermolecular ketene esterification reaction to form the crucial tertiary ester and tetrahydropyran. In addition, a novel and concise synthetic pathway towards the 1,3-syn secondary, tertiary diol fragment is described using a regio- and stereospecific electrophilic ether transfer reaction.
Keywords: electrophilic ether transfer, ketene, lyngbyaloside C, natural products, polyketides, total synthesis
Graphical Abstract
Reassigned: The total synthesis of the nomimal structure for the polyketide natural product lybyaloside C has been reported along with a correction of its originally assigned stereochemistry. Three diasteremerisomers of the compound were prepared using a highly convergent strategy.
Naturally occurring, biologically active molecules that have evolved structurally over centuries, have long served as useful therapeutics agents.[1] Polyketides, a unique class of natural products, possess a broad range of privileged scaffolds, structural diversity, and biological activities. Since 2007, a series of polyketide natural products have been isolated from the marine cyanobacteria,[2] Lyngbya bouilloni, including lyngbyaloside C (Z/E) 1, lyngbouilloside, and lyngbyaloside B (Figure 1).[3] These structures are characterized as 14-membered glycosylated macrolides, embedded with a 2,6-cis tetrahydropyran ring and an appended diene side chain. Notably, the tertiary ester moiety is not only interesting from a biosynthetic standpoint, but it also poses a unique synthetic challenge. Preliminary biological studies show that the lyngbyalosides exhibit moderate cytotoxicity against several cancer cell lines.[3] As a result, the lyngbyalosides have garnered recent interest from the synthetic community.[4] These efforts culminated in the first total synthesis of lyngbyaloside B by Fuwa et al. in 2014, in which the stereochemical configuration of lyngbyaloside B was reassigned.[4f] However, previous synthetic endeavors all focused on the lyngbyalosides which possess the (E,E) diene appendage (lyngbouilloside and lyngbyaloside B). Lyngbyaloside B also contains an additional methyl stereogenic center at C6. With that in mind, we also envisioned an intermolecular ketene esterification reaction that could generate the challenging tertiary ester from readily accessible fragments. Accordingly, lyngbyaloside C is the perfect target for the development of a general pathway to both isomers via intermolecular ketene esterification. Furthermore, the total synthesis of lyngbyaloside C would allow the confirmation of its stereochemical configuration assignment. Herein, we report the first total synthesis of lyngbyaloside C which warrants a structural revision, while providing a significant amount of material including two diastereoisomers, for more thorough biological investigation.
Figure 1.
Proposed structures of polykeide natural products isolated from Lyngbya bouilloni.
Our synthetic plan is outlined in Figure 2. We conceived that selective glycosylation of the C5 hydroxyl would allow late-stage installation of the sugar moiety. The precursory aglycone would be constructed via a highly convergent, sequential ketene esterification and ring-closing metathesis (RCM). Accordingly, the aglycone was broken into tertiary alcohol and ketene precursor fragments. Yadav et al. recently reported a similar strategy towards the synthesis of lyngbyaloside B.[4d] For preparation of the tertiary alcohol, we envisioned the installation of the 1,3-syn diol through utilization of an electrophilic-induced ether transfer methodology recently developed in our labs.[5] The alkene required for the subsequent RCM step provided us with an opportunity to explore a unique ether transfer substrate which contains potentially competing 1,1-disubstituted and terminal alkenes.
Figure 2.
Retrosynthetic analysis of lynbyaloside C.
Synthesis of the ether transfer substrate commenced with the application of a Leighton crotylation[6] of known aldehyde 2 (Scheme 1). Sequential protection of the resulting alcohol followed by a Wittig olefination furnished homoallylic alkoxy ether 6. Gratifyingly, the ether transfer reaction, carried out using iodine monchloride (ICl, −95 °C), produced the desired 1,3-syn diol monoether 7 in 76% yield with reasonable diaste-reoselectivity (10:1 syn:anti). Interestingly, no reactivity was observed at the monosubstituted olefin, representing the first report of a regioselective ether transfer in the presence of two reactive olefins. The resulting diol monoether 7 was then converted to epoxide 8 via the three-step functional group manipulation, followed by ring opening with the corresponding Grignard reagent in the presence of copper(I) iodide to afford tertiary alcohol 9 a.
Scheme 1.
Synthesis of tertiary alcohol 9a by electrophilic ether transfer reaction. Reagents and conditions: a) Z-crotyl-trichlorosilane, Leighton catalyst (R,R)-3, DBU, CH2Cl2, 0°C, 1 h; TBAF, HCl, 93%, 99%ee; b) chloromethyl-2-naphthylmethyl ether 5, DIPEA, TBAI, CH2Cl2, 40°C, 12 h, 70%; c) CH3PPh3Br, nBuLi, THF, 0°C to RT, overnight, 71 %; d) ICl, PhCH3, −95 °C, 1 min; DIPA/H2O, 3 h, 76%, d.r. = 10:1; e) TBSOTf, 2,6-lut., CH2Cl2, 0°C, 30 min, 95%; f) DDQ, CH2Cl2, pH 7 phosphate buffer, RT, 1 h, 93%; g) NaH, THF, 0°C to RT, overnight, 86%; h) 3-benzoxylpropyl magnesium bromide, CuI, THF, −78 to −15°C, 2 h, 65%. DBU: 1,8-diazabicyclo[5.4.0]undec-7-ene; TBAI: tetrabuty-lammonium iodide; DIPA: diisopropylamine; TBSOTf: trimethylsilyl trifluoro-methanesulfonate; 2,6-lut.: 2,6-lutidine; DDQ: 2,3-dichloro-5,6-dicyano-p- benzoquinone; RT: room temperature.
With tertiary alcohol 9a in hand, we then turned our focus towards the synthesis of the ketene precursor fragment. The application of ketene chemistry for the synthesis of sterically encumbered esters has been investigated.[7] On the basis of these prior studies, several ketene precursors, such as carboxylic acid I,[7a-f] acid halides II, and alkynyl ether lV[7g-I] were explored (Figure 3). Unfortunately, none of these ketene precursors proved to be efficient for generating the desired tertiary ester moiety. We believe that this is the result of the instability of the ketene intermediates and a preference for degradative over productive pathways. However, β-keto esters V have been shown to generate stabilized β-keto ketenes in the context of macrolactonization reactions.[4d] In our preliminary investigation of these precursors, low yields were obtained when we tried to scale up (~ 100 mg), which was presumably caused by the competing ketene polymerization.[7g] To address this issue, we explored the use of a thioester substrate VI activated by a thiophilic metal salt,[8] allowing the corresponding ketene to be generated under comparatively mild conditions.
Figure 3.
Ketene precursor fragments for esterification reaction.
Synthesis of β-keto ester fragment 16 started from the Mukaiyama aldol reaction of dienol ether 10 with acrolein,[9] followed by Sharpless kinetic resolution,[10] to afford chiral, non-racemic allylic alcohol 12. Desired ester 13 was accessed by trapping the acetylketene intermediate of 12 with methanol. Utilization of intramolecular hydride delivery[11] provided the 1,3-anti diol, which was subsequently silylated to afford ester 14. Reduction of the aforementioned ester with DiBALH gave the corresponding aldehyde, which was then treated with tert-butylthiol diazoacetate 15[12] in the presence of tin(II) chloride tos successfully afford β-keto- thioester 16 (Scheme 2).
Scheme 2.
Synthesis of β-keto thioester 16. Reagents and conditions: a) acrolein, SiCl4, CH2Cl2, −78°C, overnight, 80%; b) TBHP, l-(+)-DIPT, Ti(OiPr)4, MS 4 Å, CH2Cl2, −20 °C, 40 h, 90%, 99%ee; c) CH3OH, PhCH3, re-fluxing, 2 h, 90%; d) Me4NBH(OAc)3, AcOH/CH3CN, −35°C, 60 h, 92%; e) Et3SiOTf, 2,6-lut., CH2Cl2, 0 °C, 2 h to RT, 87%; f) DiBALH, CH2Cl2, −76°C, 30 min, 93%; g) tert-butylthiol diazoacetate 15, SnCl2, CH2Cl2, RT, 4 h, 80%. TBHP: tert-butylhydrogenperoxide; DiBALH: diisobutylaluminum hydride.
With the two requisite building blocks of 1 in hand, we turned our attention to developing a robust and scalable ketene esterification reaction. After screening numerous conditions, silver trifluoroacetate was found to affect gram-scale one-pot intermolecular ketene esterification in which the tertiary ester and pyran are formed consecutively to afford 17 (Scheme 3). The formation of the methyl ketal was achieved by re-fluxing with dry MeOH in the presence of citric acid, and subsequent protection of the secondary alcohol provided diene 18a. The ensuing RCM proceeded smoothly upon treatment with Hoveyda-Grubbs 2nd generation catalyst[13] in the presence of benzoquinone[14] to yield 19a exclusively as the E isomer. Regioselective hydrogenation of the disubstituted olefin and deprotection of the benzyl ether was accomplished by using activated Raney nickel, which was followed by Grieco olefination conditions[15] to provide 20a. At this point, we attempted to prepare the diene side chain through the method of Fuwa et al.[4f] Alkene 20a was converted to the aldehyde via two-step oxidation cleavage. Unfortunately, Takai olefination[16] conditions yielded vinyl iodide 21 but also resulted in an unexpected double elimination, a problem that could not be resolved.
Scheme 3.
Synthesis of macrocyclic core 20a. Reagents and conditions: a) AgTFA, Et2O (0.08 m), RT, 10 min, 73%; b) citric acid, MeOH, 70 °C, overnight, 90%; c) PMBONHCCl3, La(OTf)3, PhCH3, RT, 30 min, 80%; d) Hoyveda-Grubbs II, benzoquinone, CH3Ph (0.003 m), re-fluxing, overnight, 80%; e) H2 (1 atm), Raney Ni, MeOH, RT, overnight, 99%; f) 2-nitrophenyl seleocyanate, PBu3, THF, RT, 15 min; H2O2, NaHCO3, THF, 55 °C, 40 min, 85%; g) OsO4, NMO, CH2Cl2, RT, overnight; NaIO4, 0°C, 1 h, 78%; h) CrCl2, CHI3, 1,4-dioxane/THF, 0°C to RT, 72%. AgTFA: silver(I) trifluoroacetate; PMB: p-methoxylbenzyl; NMO: N-methylmorpholine-N-oxide.
The unexpected elimination process was successfully circumvented by use of a cross-metathesis homologation and a Wittig olefination. Deprotection of the PMB ether followed by treatment of the resultant free alcohol with the corresponding glycosylated trichloroimidate 23, in the presence of catalytic La(OTf)3[17] yielded the desired glycosylated macrolide 24a as a single β-isomer. Cross-metathesis of the terminal alkene with crotonaldehyde afforded 25 a as a single E isomer. The installation of bromodiene was completed by using Menche’s optimized Wittig reaction conditions,[18] which successfully inhibited the formation of the dibromide side product.[18] Finally, global deprotection with hydrogen fluoride furnished nominal lyngbyaloside C Z/E-1a (Z/E 4.3/1) (Scheme 4). During preliminary studies on compounds earlier in the sequence, we found that Z/E mixtures of related bromodienes could be converted to exclusively Z by exposure to catalytic quantities of DDQ. Much to our delight, DDQ treatment of a Z/E mixture of 1a provided isomerically pure Z-1a in 70% yield. At this point, the mechanism of the reaction remains unclear and the reaction may, in fact, involve selective degradation of the E-bromo-diene.
Scheme 4.
Total synthesis of nominal lyngbyaloside C. Reagents and conditions: a) DDQ, CH2Cl2, pH 7 phosphate buffer, RT, 1 h, 95%; b) 23, La(OTf)3, PhCH3, RT, 15 min, 81 %; c) crotonaldehyde, Hoveyda-Grubbs II, CH2Cl2, re-fluxing, 90%; d) Ph3PCH2BrBr, NaHMDS, HMPA, THF, RT to −78°C, 15 min, 84%, Z/E=4.3/1; e) HF, CH3CN, RT, 4 h 77%; f) DDQ, CH2Cl2, pH 7 phosphate buffer, RT, 10 min, 70%. NaHMDS: sodium bis(trimethylsilyl)amide; HMPA: hexamethylphosphoramide.
Comparing the 1H and 13C NMR data for the synthetic nominal compound 1a to those in the literature for natural lyngbyaloside C, we found there were appreciable disparities between them (Figure 4). In the 1H spectrum, the doublet at δ = 2.80 ppm and the singlet at δ = 4.57 ppm are missing in the synthetic compound. In addition, several signals in both 1H and 13C show broadening or are absent.[19] These substantial disparities indicate one or more of the stereochemical configurations of natural lyngbyaloside C and nominal structure 1a are different. During our studies, Fuwa et al. reported the synthesis of nominal lyngbyaloside B, which resulted in the structural configuration reassignment at three stereogenic centers (C10, C11, C13).[4f] Therefore, we surmised the spectral disagreements in the current effort resulted from a misassignment of lyngbyaloside C at these same positions.
Figure 4.
1H NMR (CDCl3) comparison between natural lyngbyaloside C(Z)3c and Z-1a (nominal).
Based on NOE studies of the natural product, we considered two potential diastereomers as the likely stereochemical configuration for natural lyngbyaloside C. To access both tertiary alcohol fragments 9 b and 9 c, divergent routes from a common intermediate were developed highlighted by stereochemically complementary Ti-mediated aldol reactions (Scheme 5).[20,21] Gratifyingly, fully diastereomeric targets Z/E- 1b and Z/E-1c were then generated efficiently via the optimized synthetic pathway developed for the synthesis of Z/E-1a through ketene fragment 16.[22] Upon a comparison of NMR data, 1b encountered similar irregularities with the originally proposed structure 1a. In contrast, characterization data for 1c was consistent with those of the natural product, indicating the stereochemical configuration of lyngbyaloside C is unambiguously assigned as structure 1c (Figure 5).[23] Furthermore, lyngbyaloside C shares the same absolute stereochemistry with lyngbyaloside B, and we propose that lyngbouilloside can be reassigned accordingly.
Scheme 5.
Total synthesis of diastereomers 1b and 1c and completion of the total synthesis of lyngbyaloside C.
Figure 5.
1H NMR (CDCl3) and 13C NMR comparison between natural lyngbyaloside C(Z)3c and Z-1c.
In summary, we have completed the first total synthesis of lyngbyaloisde C 1c, which has confirmed the need for reassignment of the stereochemical configuration of the natural product. Our synthetic pathway featured an intermolecular thioester transesterification through a ketene intermediate. In addition, we also developed a concise approach toward key tertiary alcohol 12a by a regio-and-stereoselective electrophilic ether transfer reaction on a unique substrate. Lastly, in synthesizing the diene bromide appendage, we determined that a catalytic DDQ-mediated isomerization could be successfully applied at a late-stage to access exclusively the Z-bromodiene for each of the three stereoisomeric compounds. The mechanism of this potentially useful methodology along with the biological evaluation of the isomeric macrolides are currently topics of investigation in our laboratory.
Supplementary Material
Acknowledgements
Support from the NIH and the National Institute for General Medical Sciences is gratefully acknowledged (GM084922). C.-F. Chang would like to acknowledge the generous support and mentorship of Dr. Yean-Jang “Super” Lee.
Footnotes
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/chem.201502132.
References
- [1].a) Firn RD, Jones CG, Nat. Prod. Rep. 2003, 20, 382; [DOI] [PubMed] [Google Scholar]; b) William PG, Trends Biotechnol. 2008, 26, 45; [Google Scholar]; c) Villa FA, Gerwick L, Immunopharm. Immunot. 2010, 32, 228; [DOI] [PubMed] [Google Scholar]; d) Mayer AMS, Glaser KB, Cuevas G, Jacobs RS, Kem W, Little RD, Mclntosh JM, Newman DJ, Potts BC, Shusters DE, Trends Pharmacol. Sci. 2010, 31, 255; [DOI] [PubMed] [Google Scholar]; e) Gerwick WH, Moore BS, Chem. Biol. 2012, 19, 85; [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Newman DJ, Cragg GM. , J. Nat. Prod. 2012, 75, 311; [DOI] [PMC free article] [PubMed] [Google Scholar]; g) Gerwick WH, Fenner AM, Microb. Ecol. 2013, 65, 800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].a) Tan LT, Phytochemistry 2007, 68, 954; [DOI] [PubMed] [Google Scholar]; b) Nunnery JK, Mevers E, Gerwick WH, Curr. Opin. Biotechnol. 2010, 21, 787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].a) Tan LT, Márquez BL, Gerwick WH, J. Nat. Prod. 2002, 65, 925; [DOI] [PubMed] [Google Scholar]; b) Luesch H, Yoshida WY, Harrigan GG, Doom JP, Moore RE, Paul VJ, J. Nat. Prod. 2002, 65, 1945; [DOI] [PubMed] [Google Scholar]; c) Matthew S, Salvador LA, Schupp PJ, Paul VJ, Luesch H, J. Nat. Prod. 2010, 73, 1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].a) Methodologies toward pyran-embeded 14-members macrolactone:Hoye TR, Danielson ME, May AE, Zhao H, Angew. Chem. Int. Ed. 2008, 47, 9743; Angew. Chem. 2008, 120, 9889; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Bai Y, Davis DC, Dai M, Angew. Chem.Int. Ed. 2014, 53, 6519; Angew. Chem. 2014, 126, 6637. Synthesis of aglycon and total synthesis: [DOI] [PMC free article] [PubMed] [Google Scholar]; c) ElMarrouni A, Lebeuf R, Gebauer J, Heras M, Stellios A, Cossy J, Org. Lett. 2012, 14, 314; [DOI] [PubMed] [Google Scholar]; d) Yadav JS, Haldar A, Maity T, Eur. J. Org. Chem. 2013, 3076; [Google Scholar]; e) Fuwa H, Yamagata N, Saito A, Sasaki M, Org. Lett. 2013, 15, 1630; [DOI] [PubMed] [Google Scholar]; f) Fuwa H, Okuaki Y, Yamagata N, Sasaki M, Angew. Chem. Int. Ed. 2015, 54, 868; Angew. Chem. 2015, 127, 882. [DOI] [PubMed] [Google Scholar]
- [5].a) Liu K, Taylor RE, Kartika R, Org. Lett. 2006, 8, 5393; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Kartika R, Taylor RE, Angew. Chem. Int. Ed. 2007, 46, 6874; Angew. Chem. 2007, 119, 6998; [DOI] [PubMed] [Google Scholar]; c) Kartika R, Frein JD, Taylor RE, J. Org. Chem. 2008, 73, 5592; [DOI] [PubMed] [Google Scholar]; d) Kartika R, Gruffi TR, Taylor RE, Org. Lett. 2008, 10, 5047; [DOI] [PubMed] [Google Scholar]; e) Liu K, Arico JW, Talyor RE, J. Org. Chem. 2010, 75, 3953; [DOI] [PubMed] [Google Scholar]; f) Wilson MR, Taylor RE, Org. Lett. 2012, 14, 3408; [DOI] [PMC free article] [PubMed] [Google Scholar]; g) Stefan E, Taylor RE, Org. Lett. 2012, 14, 3490; [DOI] [PMC free article] [PubMed] [Google Scholar]; h) Stefan E, Nalin AP, Taylor RE, Tetrahedron 2013, 69, 7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].a) Suen LM, Steigerwald ML, Leighton JL, Chem. Sci. 2013, 4, 2413; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Ho S, Bucher C, Leighton JL, Angew. Chem. Int. Ed. 2013, 52, 6757; Angew. Chem. 2013, 125, 6889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].a) Funk RL, Abelman MM, Jellison KM, Synlett 1989, 36; [Google Scholar]; <lit b>Shelkov R, Nahmany M, Melmann A, J. Org. Chem. 2002, 67, 8975; [DOI] [PubMed] [Google Scholar]; c) Shelkov R, Nahmany M, Melmann A, Org. Biomol. Chem. 2004, 2, 397; [DOI] [PubMed] [Google Scholar]; d) Paquette LA, Efremov I, J. Org. Chem. 2005, 70, 510; [DOI] [PubMed] [Google Scholar]; e) Sano S, Ichikawa T, Nakao M, Nagao Y, Chem. Lett. 2012, 41, 68; [Google Scholar]; f) Zhong Y-L, Gauthier DR Jr. , Shi Y-J, McLaughlin M, Chung JYL, Dagneau P, Marcune B, Krska SW, Ball RG, Reamer RA, J. Org. Chem. 2012, 77, 3297; [DOI] [PubMed] [Google Scholar]; g) Peric$s MA, Serratosa F, Valentí E, Tetrahedron 1987, 43, 2311; [Google Scholar]; h) Magriotis PA, Vourloumis D, Scott ME, Tarli A, Tetrahedron Lett. 1993, 34, 2071; [Google Scholar]; i) Liang L, Ramaseshan M, MaGee DI, Tetrahedron 1993, 49, 2159; [Google Scholar]; j) Moslin RM, Jamison TF, J. Am. Chem. Soc. 2006, 128, 15106; [DOI] [PMC free article] [PubMed] [Google Scholar]; k) Hoye TR, Danielson ME, May AE, Zhao H, J. Org. Chem. 2010, 75, 7052; [DOI] [PMC free article] [PubMed] [Google Scholar]; l) Tran V, Minehan TG, Org. Lett. 2011, 13, 6588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].a) Booth PM, Fox CMJ, Ley SV, J. Chem. Soc. Perkin Trans. 1 1987, 121; [Google Scholar]; b) Park PU, Broka CA, Johnson BF, Kishi Y, J. Am. Chem. Soc. 1987, 109, 6205; [Google Scholar]; c) Clarke T, Ley SV, J. Chem. Soc. Perkin Trans. 1 1987, 1, 131–135; [Google Scholar]; d) Ley SV, Woodward PR, Tetrahedron Lett. 1987, 28, 345–346; [Google Scholar]; e) Fox CMJ, Ley SV, Org. Synth. 1988, 66, 108–115; [Google Scholar]; f) Booth PM, Broughton HB, Ford MJ, Fox CMJ, Ley SV, Slawin AMZ, Williams DJ, Woodward PR, Tetrahedron 1989, 45, 7565–7580; [Google Scholar]; g) Parenty A, Moreau X, Niel G, Campagne J-M, Chem. Rev. 2013, 113, PR1. [DOI] [PubMed] [Google Scholar]
- [9].a) Denmark SE, Beutner GL, Wynn T, Eastgate MD, J. Am. Chem. Soc. 2005, 127, 3774; [DOI] [PubMed] [Google Scholar]; b) Navarro I, Basset J-F, Hebbe S, Major SM, Werner T, Howsham C, Bräckow J, Barrett AGM, J. Am. Chem. Soc. 2008, 130, 10293. [DOI] [PubMed] [Google Scholar]
- [10].Sugita Y, Sakaki J-I, Sato M, Kaneko C, J. Chem. Soc. Perkin Trans. 1 1992, 2855 [Google Scholar]
- [11].Evans DA, Chapman KT, Carreira EM, J. Am. Chem. Soc. 1988, 110, 3560. [Google Scholar]
- [12].Danheiser RL, Miller RF, Brisbois RG, J. Org. Chem. 1990, 55, 1959. [Google Scholar]
- [13].Gradillas A, Pérez-Castells J, Angew. Chem. Int. Ed. 2006, 45, 8086; Angew. Chem. 2006, 118, 8264. [DOI] [PubMed] [Google Scholar]
- [14].Hong SH, Sanders DP, Lee CW, Grubbs RH, J. Am. Chem. Soc. 2005, 127, 1716. [DOI] [PubMed] [Google Scholar]
- [15].a) Grieco PA, Gilman S, Nishizawa M, J. Org. Chem. 1976, 41, 1485; [Google Scholar]; b) Sharpless KB, Young MW, J. Org. Chem. 1975, 40, 7. [Google Scholar]
- [16].a) Takai K, Nitta K, Utimoto K, J. Am. Chem. Soc. 1986, 108, 7408; [DOI] [PubMed] [Google Scholar]; b) Evans DA, Black WC, J. Am. Chem. Soc. 1993, 115, 4497. [Google Scholar]
- [17].Notably, during the screening of the glycosylation conditions, we found that the hemiketal pyran is a highly acid-sensitive moiety; acids like TrClO4, TBSOTf, TMSOTf, PPTS, and AgClO4, lead to either double eliminated product (similar to 21), or decomposition of starting material.
- [18].Li P, Li J, Arikan F, Ahlbrecht W, Dieckmann M, Menche D, J. Org. Chem. 2010, 75, 2429. [DOI] [PubMed] [Google Scholar]
- [19].See Supporting Information; Table S1; Figure S2.
- [20].a) Crimmins MT, Chaudhary K, Org. Lett. 2000, 2, 775; [DOI] [PubMed] [Google Scholar]; b) Crimmins MT, King BW, Tabet EA, Chaudhary K, J. Org. Chem. 2001, 66, 869. [DOI] [PubMed] [Google Scholar]
- [21].See Supporting Information; Scheme S3.
- [22].See supporting information; Scheme S4.
- [23].See Supporting Information;
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.